Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
…
continue reading
Medicalapps Podcasts
1
Turning Cold Tumors Hot to Effectively Treat Triple-Negative Breast Cancer with Dr. Jay Lalezari CytoDyn TRANSCRIPT
Dr. Jay Lalezari, CEO of CytoDyn, is focused on solid tumor immunology, particularly in triple-negative breast cancer, where their lead drug, leronlimab, is showing significant long-term survival benefits. This monoclonal antibody targets the CCR5 receptor, converting cold tumors into hot tumors and making them more susceptible to immunotherapy che…
…
continue reading
1
Turning Cold Tumors Hot to Effectively Treat Triple-Negative Breast Cancer with Dr. Jay Lalezari CytoDyn
19:25
19:25
Play later
Play later
Lists
Like
Liked
19:25
Dr. Jay Lalezari, CEO of CytoDyn, is focused on solid tumor immunology, particularly in triple-negative breast cancer, where their lead drug, leronlimab, is showing significant long-term survival benefits. This monoclonal antibody targets the CCR5 receptor, converting cold tumors into hot tumors and making them more susceptible to immunotherapy che…
…
continue reading
1
Advancing Research on Ataxia for Development of Therapeutics and Patient Education with Andrew Rosen NAF TRANSCRIPT
Andrew Rosen, Chief Executive Officer of the National Ataxia Foundation, has a dual mission of accelerating research for treatments and cures for Ataxia while supporting the patients affected by this rare disease. Ataxia describes both a group of hereditary genetic diseases and symptoms of lack of coordination seen in other conditions. While geneti…
…
continue reading
1
Advancing Research on Ataxia for Development of Therapeutics and Patient Education with Andrew Rosen NAF
19:24
19:24
Play later
Play later
Lists
Like
Liked
19:24
Andrew Rosen, Chief Executive Officer of the National Ataxia Foundation, has a dual mission of accelerating research for treatments and cures for Ataxia while supporting the patients affected by this rare disease. Ataxia describes both a group of hereditary genetic diseases and symptoms of lack of coordination seen in other conditions. While geneti…
…
continue reading
1
Medical App for Medication Management Supports Clinicians and Patients with Anne Meneghetti epocrates TRANSCRIPT
Anne Meneghetti, Executive Director of epocrates, is focused on medication management and providing tools for clinicians to better handle challenges from the increasing population of patients who take multiple drugs and are treating a wide variety of conditions. The epocrates app provides access to drug information, pill identification, checks for …
…
continue reading
1
Medical App for Medication Management Supports Clinicians and Patients with Anne Meneghetti epocrates
27:37
27:37
Play later
Play later
Lists
Like
Liked
27:37
Anne Meneghetti, Executive Director of epocrates, is focused on medication management and providing tools for clinicians to better handle challenges from the increasing population of patients who take multiple drugs and are treating a wide variety of conditions. The epocrates app provides access to drug information, pill identification, checks for …
…
continue reading
1
New Biologic Drug for Rare IgG4-Related Disease with Dr. Adam Kilian St. Louis University School of Medicine TRANSCRIPT
Dr. Adam Kilian, Director of the Rheumatology Fellowship Training Program at the St. Louis University School of Medicine, focuses on IgG4-related disease, a rare multi-organ disease that has only recently been recognized due to significant diagnostic challenges. The MITIGATE trial is a landmark study that demonstrated that the first FDA-approved tr…
…
continue reading
1
New Biologic Drug for Rare IgG4-Related Disease with Dr. Adam Kilian St. Louis University School of Medicine
21:10
21:10
Play later
Play later
Lists
Like
Liked
21:10
Dr. Adam Kilian, Director of the Rheumatology Fellowship Training Program at the St. Louis University School of Medicine, focuses on IgG4-related disease, a rare multi-organ disease that has only recently been recognized due to significant diagnostic challenges. The MITIGATE trial is a landmark study that demonstrated that the first FDA-approved tr…
…
continue reading
1
Early Detection of Alzheimer's Disease Critical to Managing the Rising Dementia Epidemic with Dr. Thomas Wisniewski NYU Langone TRANSCRIPT
Dr. Thomas Wisniewski, Director of NYU Langone's Alzheimer's Disease Research Center, shares insights from a recent study that projects new dementia cases in the US will double by 2060. New diagnostic tools have made it easier to identify early signs of Alzheimer's, and disease-modifying therapies are being approved, which can be effective if patie…
…
continue reading
1
Early Detection of Alzheimer's Disease Critical to Managing the Rising Dementia Epidemic with Dr. Thomas Wisniewski NYU Langone
22:40
22:40
Play later
Play later
Lists
Like
Liked
22:40
Dr. Thomas Wisniewski, Director of NYU Langone's Alzheimer's Disease Research Center, shares insights from a recent study that projects new dementia cases in the US will double by 2060. New diagnostic tools have made it easier to identify early signs of Alzheimer's, and disease-modifying therapies are being approved, which can be effective if patie…
…
continue reading
1
Small Pediatric Practices Overcome Challenges of Vaccine Management with Pedro Sanchez de Lozada Canid TRANSCRIPT
Pedro Sanchez de Lozada, CEO of Canid, highlights the significant financial risks that pediatricians face in managing their vaccine inventory. There are administrative burdens associated with ordering, patient demand, tracking, reporting, and filing for insurance reimbursement. The Canid platform was designed to be a vaccine-as-a-service model, rem…
…
continue reading
1
Small Pediatric Practices Overcome Challenges of Vaccine Management with Pedro Sanchez de Lozada Canid
24:04
24:04
Play later
Play later
Lists
Like
Liked
24:04
Pedro Sanchez de Lozada, CEO of Canid, highlights the significant financial risks that pediatricians face in managing their vaccine inventory. There are administrative burdens associated with ordering, patient demand, tracking, reporting, and filing for insurance reimbursement. The Canid platform was designed to be a vaccine-as-a-service model, rem…
…
continue reading
Alicia Silver, senior director at ADVI Health, highlights the evolving landscape of cell and gene therapy and the need to improve patient access and payment for these treatments. Availability of these therapies for solid tumors and genetic diseases like sickle cell disease is expanding due to the transition from inpatient to outpatient and communit…
…
continue reading
1
Accelerating Access to Cell and Gene Therapies with Alicia Silver ADVI Health
20:35
20:35
Play later
Play later
Lists
Like
Liked
20:35
Alicia Silver, senior director at ADVI Health, highlights the evolving landscape of cell and gene therapy and the need to improve patient access and payment for these treatments. Availability of these therapies for solid tumors and genetic diseases like sickle cell disease is expanding due to the transition from inpatient to outpatient and communit…
…
continue reading
1
DNA-Based Immunotherapy Poised to Transform Ovarian Cancer Treatment with Dr. Stacy Lindborg IMUNON TRANSCRIPT
Dr. Stacy Lindborg, President and CEO of IMUNON, has developed a DNA-based immunotherapy candidate for the treatment of ovarian cancer. This therapy works by administering the drug, which utilizes IL-12, a powerful anti-cancer cytokine, directly into the cavity where the cancer resides, thereby affecting the tumor microenvironment. Trials are showi…
…
continue reading
1
DNA-Based Immunotherapy Poised to Transform Ovarian Cancer Treatment with Dr. Stacy Lindborg IMUNON
20:57
20:57
Play later
Play later
Lists
Like
Liked
20:57
Dr. Stacy Lindborg, President and CEO of IMUNON, has developed a DNA-based immunotherapy candidate for the treatment of ovarian cancer. This therapy works by administering the drug, which utilizes IL-12, a powerful anti-cancer cytokine, directly into the cavity where the cancer resides, thereby affecting the tumor microenvironment. Trials are showi…
…
continue reading
Donovan Campbell, CEO of Medbridge, empowers clinicians through a platform that is focused on movement-based medicine and a holistic approach to patient care. MedBridge has developed AI tools to perform triage, act as a care coordinator, and serve as a patient-facing coach, offloading administrative tasks and providing better support to patients. T…
…
continue reading
1
AI-Powered Movement-Based Medicine Platform with Donovan Campbell Medbridge
21:09
21:09
Play later
Play later
Lists
Like
Liked
21:09
Donovan Campbell, CEO of Medbridge, empowers clinicians through a platform that is focused on movement-based medicine and a holistic approach to patient care. MedBridge has developed AI tools to perform triage, act as a care coordinator, and serve as a patient-facing coach, offloading administrative tasks and providing better support to patients. T…
…
continue reading
1
Accessible Genetic Tests for Reproductive Carrier and Hereditary Cancer Screening and Evaluation of Options with Dr. Matt Goldstein jscreen TRANSCRIPT
Dr. Matt Goldstein, CEO of jscreen, focuses on the importance and power of preventive genetic testing for reproductive carrier screening and hereditary cancer screening. All genetic tests include analysis to inform specific medical management plans and provide genetic counselors to explore options. Of particular interest is testing for the gene mut…
…
continue reading
1
Accessible Genetic Tests for Reproductive Carrier and Hereditary Cancer Screening and Evaluation of Options with Dr. Matt Goldstein jscreen
20:26
20:26
Play later
Play later
Lists
Like
Liked
20:26
Dr. Matt Goldstein, CEO of jscreen, focuses on the importance and power of preventive genetic testing for reproductive carrier screening and hereditary cancer screening. All genetic tests include analysis to inform specific medical management plans and provide genetic counselors to explore options. Of particular interest is testing for the gene mut…
…
continue reading
1
Significance of Regulatory RNA in Protein Production in Specific Genes with Dr. Yuri Maricich CAMP4 Therapeutics TRANSCRIPT
Dr. Yuri Maricich, Chief Medical Officer at CAMP4 Therapeutics, describes regulatory RNA, a new area of biology that recognizes the role of Reg RNA in the production of proteins from specific genes. This technology is well-suited for haploinsufficient diseases such as SYNGAP1-related disorders, in which there is a lack of healthy protein and both p…
…
continue reading
1
Significance of Regulatory RNA in Protein Production in Specific Genes with Dr. Yuri Maricich CAMP4 Therapeutics
18:46
18:46
Play later
Play later
Lists
Like
Liked
18:46
Dr. Yuri Maricich, Chief Medical Officer at CAMP4 Therapeutics, describes regulatory RNA, a new area of biology that recognizes the role of Reg RNA in the production of proteins from specific genes. This technology is well-suited for haploinsufficient diseases such as SYNGAP1-related disorders, in which there is a lack of healthy protein and both p…
…
continue reading
1
DNA Immunotherapy Shows Durable Response in Advanced Melanoma with Phil L'Huillier Scancell TRANSCRIPT
Phil L'Huillier, CEO of Scancell, has developed an off-the-shelf DNA immunotherapy designed to generate a potent and durable immune response against advanced melanoma in patients who are unresponsive to current therapies. Their lead candidate showed significant benefit when added to standard of care checkpoint inhibitors, improving duration of resp…
…
continue reading
1
DNA Immunotherapy Shows Durable Response in Advanced Melanoma with Phil L'Huillier Scancell
23:49
23:49
Play later
Play later
Lists
Like
Liked
23:49
Phil L'Huillier, CEO of Scancell, has developed an off-the-shelf DNA immunotherapy designed to generate a potent and durable immune response against advanced melanoma in patients who are unresponsive to current therapies. Their lead candidate showed significant benefit when added to standard of care checkpoint inhibitors, improving duration of resp…
…
continue reading
1
Peptide Therapy for Low T Restores Natural Testosterone Production with Dr. Costas Karatzas Acesis BioMed TRANSCRIPT
Dr. Costas Karatzas, CEO, Director, and Co-Founder of Acesis BioMed, is focused on developing a novel treatment for low testosterone in men, an oral peptide that stimulates the body to restore its own natural testosterone production. The therapy's mechanism differs from current testosterone replacement therapies and avoids the side effect of infert…
…
continue reading
